The positive expression rate of KRT80 in the ovarian cancer group (79.41%, 81/102) was also higher than that in ovarian borderline group (75.00%, 12/16), but the difference was not statistically significant (P > 0.05). Here, KRT80 is linked to ovarian carcinoma.